Abstract

Introduction: Extracorporeal Membrane Oxygenation (ECMO) and Inhaled Anesthetics (IA) are considered in the management of Near-Fatal Asthma (NFA) refractory to conventional therapy. We sought to compare these two modalities in children. Methods: This is a retrospective study using the Virtual Pediatric Systems Database, (VPS, LLC). We included patients < 18 years of age with NFA treated with IA and/or ECMO between January 2010 and December 2020. Primary outcome was survival to hospital discharge. Results: A total of 221 patients were included in the study; 149 (67%) received only ECMO, 62 (28%) received only IA and 10 (5%) patients received both. There was no difference in age, PIM3, PRISM3, PELOD scores, pre-intervention pH or pCO2 between the ECMO and lA groups. The ECMO group had lower pre-intervention PaO2 (60 vs 78mmHg, p < 0.001) and higher utilization of high frequency oscillatory ventilation compared to the IA cohort. Pre intervention heliox was used more frequently in the lA group (p < 0.001). There was no difference in survival to hospital discharge; 128/149 (86%) in ECMO and 57/62 (92%) in IA (p=0.38) cohorts. The ECMO group had longer duration of intervention (5 vs 1.3 days, p< 0.001), more frequent mid intervention cardiac arrest (7% vs 2%, p= 0.04), longer ICU length of stay (LOS) (13 vs 7 days p< 0.001) and required more bronchoscopies (34% vs 11% p< 0.001). Post-intervention mechanical ventilation was similar among survivors (p=0.38). Conclusions: In our study, ECMO and IA had comparable survival to hospital discharge. However, ECMO was associated with higher risk of complications and ICU LOS.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call